PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAdienne
Adienne
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
PhelinunMelphalan2020-11-162029-2036
Myeloid leukemia acute
,
Breast neoplasms
,
Ovarian neoplasms
,
Non-hodgkin lymphoma
,
Multiple myeloma
,
Neuroblastoma
,
Precursor cell lymphoblastic leukemia-lymphoma
,
Hematopoietic stem cell transplantation
,
Hodgkin disease
,
Rhabdomyosarcoma
TepadinaThiotepa2017-01-26
Breast neoplasms
,
Ovarian neoplasms
,
Sarcoma
,
Lymphoma
,
Urinary bladder neoplasms
,
Hematopoietic stem cell transplantation
,
Adenocarcinoma
,
Neoplasms
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Thiotepa
lymphoma
,
leukemia
,
myelodysplastic syndromes
,
myeloid leukemia acute
,
myeloid leukemia
Mycophenolate sodium
healthy volunteers/patients
,
malnutrition
,
lupus nephritis
,
systemic lupus erythematosus
,
nephritis
,
autoimmune diseases
Mycophenolic acid
healthy volunteers/patients
,
malnutrition
,
lupus nephritis
,
systemic lupus erythematosus
,
nephritis
,
autoimmune diseases
Begelomab
urinary bladder neoplasms
,
graft vs host disease
Globulin, immune
encephalitis
,
japanese encephalitis
,
chikungunya fever
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use